| Clinical Study to Evaluate the Effects of Oral Delta-9-tetrahydrocannabinol (Δ9-THC) With and Without Alcohol on Perception and Driving Performance in Healthy Adults (NCT07176208) | Food and Drug Administration (FDA) | 2025-12-29 |
| Clinical Study to Evaluate Cannabidiol Liver Enzyme Elevations and Drug Interactions (NCT06192589) | Food and Drug Administration (FDA) | 2024-02-08 |
| Electrophysiological Effects of Potential QT Prolonging Drugs (NCT05716854) | Food and Drug Administration (FDA) | 2023-03-21 |
| Effect of Selective Serotonin Reuptake Inhibitors (SSRIs) and an Opioid on Ventilation (NCT05470465) | Food and Drug Administration (FDA) | 2022-09-01 |
| Human Perception on Medical Extended Reality Devices (NCT05479019) | Food and Drug Administration (FDA) | 2022-07-01 |
| Assessing Variability of the Ventilatory Response to Duffin's Rebreathing Procedure (NCT05168501) | Food and Drug Administration (FDA) | 2021-12-27 |
| Adaptive Optics Imaging of Outer Retinal Diseases (NCT05355415) | Food and Drug Administration (FDA) | 2021-08-27 |
| Clinical Study to Investigate the Pharmacokinetics of Multiple Repeated Doses of Intranasal Naloxone (NCT04764630) | Food and Drug Administration (FDA) | 2021-03-01 |
| Clinical Study to Investigate the Effect of the Combination of Psychotropic Drugs and an Opioid on Ventilation (NCT04310579) | Food and Drug Administration (FDA) | 2020-06-15 |
| Clinical Study to Investigate the Urinary Excretion of N-nitrosodimethylamine (NDMA) After Ranitidine Administration (NCT04397445) | Food and Drug Administration (FDA) | 2020-06-08 |
| Pharmacodynamic Biomarkers to Support Biosimilar Development: Interferon Beta-1A Products (NCT04183491) | Food and Drug Administration (FDA) | 2020-02-28 |
| Pharmacodynamic Biomarkers to Support Biosimilar Development: Interleukin-5 Antagonists (NCT04183192) | Food and Drug Administration (FDA) | 2020-02-17 |
| Assessment of the Human Systemic Absorption of Sunscreen Ingredients (NCT03582215) | Food and Drug Administration (FDA) | 2018-07-18 |
| Adaptive Optics Retinal Imaging (NCT05370287) | Food and Drug Administration (FDA) | 2018-01-22 |